Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area epigenetics hypoxia inducible factors'

Search results for: 'research area epigenetics hypoxia inducible factors'

Items 21-30 of 171

Page
per page
  1. Tubacin
    A4501 Tubacin
     3 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC6 inhibitor,potent,selective,reversible,cell-permeable
      insoluble in EtOH; insoluble in H2O; ≥7.19 mg/mL
  2. Tenovin-6
    A8302 Tenovin-6
    Target: Sir2-like Family Deacetylases (Sirtuins)
    Summary: SIRT inhibitor and p53 activator
      ≥22.75 mg/mL
  3. SRT2104 (GSK2245840)
    A3821 SRT2104 (GSK2245840)
     1 Citation
    Target: Sir2-like Family Deacetylases (Sirtuins)
    Summary: SIRT1 activator,selective
      insoluble in H2O; insoluble in EtOH; ≥6.46 mg/mL
  4. Ruxolitinib (INCB018424)
    A3012 Ruxolitinib (INCB018424)
     4 Citation
    Target: JAK
    Summary: JAK inhibitor
      insoluble in H2O; ≥15.32 mg/mL
  5. Tofacitinib (CP-690550) Citrate
    A4135 Tofacitinib (CP-690550) Citrate
     2 Citation
    Target: JAK
    Summary: Potent JAK inhibitor
      ≥25.22 mg/mL
  6. LY2784544
    A4147 LY2784544
    Target: Aurora Kinases|FLT3|VEGFR|FGFR|Trk Receptors|JAK|ALK|TYK2|MUSK|MAP3K
    Summary: JAK2 inhibitor,highly potent and selective
      ≥23.5 mg/mL
  7. SRT1720 HCl
    A4180 SRT1720 HCl
     3 Citation
    Target: Sir2-like Family Deacetylases (Sirtuins)
    Summary: SIRT1 activator
      ≥25.3 mg/mL
  8. EX 527 (SEN0014196)
    A4181 EX 527 (SEN0014196)
     1 Citation
    Target: Sirtuin
    Summary: SIRT1 inhibitor
      insoluble in H2O; ≥12.43 mg/mL
  9. Pracinostat (SB939)
    A4095 Pracinostat (SB939)
     2 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: Pan-HDAC inhibitor
      insoluble in H2O; ≥11.4 mg/mL
  10. Belinostat (PXD101)
    A4096 Belinostat (PXD101)
     2 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: Hydroxamate-type HDAC inhibitor
      insoluble in H2O; ≥15.92 mg/mL

Items 21-30 of 171

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 166item
  2. Natural Products 6item
  3. Lab Reagents 1 item
Specificity
  1. Selective 114item
Reversibility
  1. Reversible 5item
  2. Irreversible 4item
Target
  1. Caspases 2item
  2. Cyclin-Dependent Kinases 1 item
  3. Proteasome 1 item
  4. Histone Deacetylases (HDACs) 21item
  5. Bcl-2 1 item
  6. PI3K 1 item
  7. Raf 2item
  8. Aurora Kinases 13item
  9. Bcl-xl 1 item
  10. CSF-1R 3item
  11. EZH2 1 item
  12. Bromodomains 3item
  13. AP-1 2item
  14. MMP 2item
  15. DT-diaphorases 1 item
  16. FLT3 6item
  17. Factor Xa 4item
  18. LPA Receptors 1 item
  19. PLK 2item
  20. VEGFR 13item
  21. PDGFR 7item
  22. c-Kit 4item
  23. RET 1 item
  24. Bromodomain-containing proteins(BRDs) 1 item
  25. Phosphodiesterases (PDEs) 1 item
  26. Mcl-1 1 item
  27. Hydrolase 1 item
  28. SGK 1 item
  29. DOT1L 1 item
  30. FGFR 7item
  31. Nrf2 2item
  32. Insulin-like growth factor receptors(IGFRs) 1 item
  33. Pim 1 item
  34. Liver X receptors (LXRs) 1 item
  35. Sir2-like Family Deacetylases (Sirtuins) 4item
  36. Deubiquitinating enzymes (DUBs) 1 item
  37. PP1 1 item
  38. PP2A 1 item
  39. Smoothened 1 item
  40. MET 1 item
  41. Src 2item
  42. Trk Receptors 1 item
  43. Aminopeptidases 1 item
  44. STAT 2item
  45. Estrogen and Related Receptors 1 item
  46. EGFR 8item
  47. RIP kinases 1 item
  48. Hypoxia Inducible Factors (HIFs) 2item
  49. JAK 9item
  50. DNA-PK 1 item
  51. HSP90 1 item
  52. Topoisomerases 2item
  53. Cytochrome P450 (CYP450) 1 item
  54. ErbB 3item
  55. Toll-like receptors (TLRs) 1 item
  56. Actin 1 item
  57. DNA Methyltransferases 2item
  58. Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs) 1 item
  59. ERK 1 item
  60. PKC 1 item
  61. CREBBP 1 item
  62. EP300 1 item
  63. Lyn 1 item
  64. HER2 1 item
  65. LRRK2 1 item
  66. Insulin and Insulin-like Receptors 2item
  67. PARP 2item
  68. CB1 Receptors 1 item
  69. ALK 1 item
  70. Dehydrogenase 1 item
  71. Fatty-acid-binding proteins (FABPs) 1 item
  72. Free Fatty Acid Receptors 1 item
  73. phosphatases 1 item
  74. Autophagy 2item
  75. C5a receptors 1 item
  76. Farnesyl Diphosphate Synthases 1 item
  77. MAGL 1 item
  78. Histamine H1 Receptors 2item
  79. Hck 1 item
  80. TRP Channel 2item
  81. NO Donors / Precursors 2item
  82. CB2 Receptors 1 item
  83. Glucocorticoid Receptors 1 item
  84. IL Receptors 1 item
  85. 15-lipoxygenases 1 item
  86. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  87. Cytidine deaminases 1 item
  88. PP4 1 item
  89. c-RET 1 item
  90. FPTase 1 item
  91. VEGFR3/FLT4 1 item
  92. NTRK1/TRKA 1 item
  93. CSF-1R/c-Fms 1 item
  94. PTP 1 item
  95. p53 3item
  96. HDAC 1 item
  97. c-Fms tyrosine kinase 1 item
  98. insulin 1 item
  99. PPAR 1 item
  100. HDM2 ubiquitin ligase 1 item
  101. Elastases 1 item
  102. Glucosidases 1 item
  103. GLI 1 item
  104. HIV 1 item
  105. Histone Acetyltransferases (HATs) 1 item
  106. Telomerases 1 item
  107. Trx 1 item
  108. Tyrosinases 1 item
  109. phosphatidylinositol kinase 1 item
  110. TYK2 1 item
  111. MUSK 1 item
  112. MAP3K 1 item
  113. Adenosine Deaminases 1 item
  114. p21 1 item
  115. FGR 1 item
  116. YES 1 item
  117. Fyn 1 item
  118. ARG 1 item
  119. RHA 1 item
  120. TRPC channel 1 item
  121. FKBP 1 item
  122. Sirtuin 1 item
  123. NS3/4a Proteases 1 item
Related Disease
  1. Acute Lung Injury 1 item
  2. Acute Myeloid Leukemia 8item
  3. Adrenocortical Carcinoma 1 item
  4. Bladder Cancer 4item
  5. Bladder Carcinoma 1 item
  6. Breast Cancer 27item
  7. Cancer 104item
  8. Cervical Cancer 3item
  9. Chronic Lymphocytic Leukemia 1 item
  10. Chronic Myeloproliferative Disorders 1 item
  11. Colon Cancer 10item
  12. Colon Carcinoma 1 item
  13. Colorectal Cancer 9item
  14. Diabetes 1 item
  15. Glioblastoma 8item
  16. Glioma 2item
  17. HCV 1 item
  18. Hepatic Cancer 1 item
  19. Hepatocellular Carcinoma 1 item
  20. HIV 2item
  21. HIV Infections 1 item
  22. Inflammatory Diseases 3item
  23. Leukemia 3item
  24. Liver Cancer 2item
  25. Lung Cancer 8item
  26. Lung Carcinoma 1 item
  27. Lymphoma 5item
  28. Melanoma 5item
  29. Mixed Lineage Leukemia 1 item
  30. Multiple Myeloma 7item
  31. Myelofibrosis 2item
  32. Myeloma 2item
  33. Neuroblastoma 1 item
  34. Neuronal Protection 1 item
  35. Non-small Cell Lung Cancer 7item
  36. Ovarian Cancer 9item
  37. Pain Relief 1 item
  38. Pancreatic Cancer 11item
  39. Pentacyclic Triterpenoid 1 item
  40. Prostate Cancer 17item
  41. Psoriasis 1 item
  42. Pulmonary Arterial Hypertension 1 item
  43. Pulmonary Fibrosis 1 item
  44. Renal Cancer 1 item
  45. Renal Cell Carcinoma 5item
  46. Rheumatoid Arthritis 2item
  47. Sleep Disorders 1 item
  48. Soft Tissue Sarcoma 1 item
  49. Testicular Cancer 1 item
  50. Thyroid Cancer 2item
  51. Type 2 Diabetes 3item